ArriVent BioPharma, Inc. (NASDAQ:AVBP) IPO

ArriVent BioPharma, Inc.

IPO

Priced at US$18.00 a share on Jan 25, 2024.

Price
US$18.00 a share
Shares offered
9,722,222 shares of common stock
Offering size
US$175 million
Underwriters' option
Up to 1,458,333 more shares
Listing
AVBP on the Nasdaq Global Market
Underwriters
Goldman Sachs & Co. LLC, Jefferies, Citigroup, LifeSci Capital · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceAug 25, 2023
Filed publiclyJan 5, 2024
Amended twiceNewest Jan 23, 2024
Shares registered with an exchangeJan 23, 2024
Declared effective by the SECJan 25, 2024
Final prospectus, with the priceJan 26, 2024

From the cover of the final prospectus (424B4) filed Jan 26, 2024